首页 医师介绍详细
何勇

何勇

硕士研究生 科室: 药剂科
擅长: 生物药物分析及药事管理

生物药物分析及药事管理

医生介绍

党支部书记,科主任,GCP办公室副主任,博士,博士生导师,主任药师中国药理学会治疗药物监测研究专业委员会委员;中国医药教育协会抗肿瘤用药研究与评价分会常委;中国药理学会药物代谢专业委员会青年委员贵州省千层次创新型人才;贵州省药品注册审批专家;贵州省药理学会理事;贵州省药学会理事贵州省药学会药物分析专业委员会副主任委员;贵州省药学会临床药学专业委员会副主任委员;贵州省药学会妇产科疾病治疗专业委员会副主任委员;贵州省医学会临床药学委员会常委;贵州省药学会药学服务专业委员会常委;贵州省医院协会药事管理专委会常委主持国家自然科学基金、国家卫健委、省科技厅重点项目等项目8项;承担国家药品监督管理局“十四五”规划前期重大研究课题2项;编制贵州省省级“十四五”规划1《中国药房》网络版编委、《现代医药卫生》青年编委、 Biosens BioelectronIF=10.7)等期刊审稿人Biosens Bioelectron, ACS Sens, Anal Chem, Anal Chim Acta, Sens Actuators, B, Microchimica Acta等发表SCI论文22篇(2IF > 1016IF > 5),累计影响因子143

1. He Yong, Wang Mengyao, Fan Enci, Ouyang Hui, Yue Huan, Su Xiaoxiao, Liao Guojian, Wang Ling, Lu Shuguang, Fu Zhifeng. Highly specific bacteriophage-affinity strategy for rapid separation and sensitive detection of viable Pseudomonas aeruginosa. Anal. Chem. 2017, 89, 1916-19211IF 6.04.

2. He Yong, Shi Yanli, Liu Mengli, Wang Yingran, Wang Ling, Lu Shuguang, Fu Zhifeng. Nonlytic recombinant phage tail fiber protein for specific recognition of Pseudomonas aeruginosa. Anal. Chem. 2018, 90, 14462-14468 1IF 6.35.(第一作者)

3. He Yong, Wang Yingran, Shi Yanli, Fu Zhifeng. Molecular recognition strategy for detection and antimicrobial susceptibility testing of Staphylococcus aureus by utilizing teicoplanin and porcine IgG as indicator molecules. Sens. Actuators, B. 2018, 267, 51-571IF 6.39. (第一作者)

4. He Yong, Fan Enci, Wang Mengyao, Lu Shuguang, Fu Zhifeng. Antimicrobial susceptibility testing by using virulent phages to evaluate bacterial viability. Anal. Methods 2018, 10, 1799-18043IF 2.07.(第一作者)

5. Shi Yanli, He Yong, Zhang Lvxia, Wang Lin, Fu Zhifeng. Dual-site recognition of Pseudomonas aeruginosa using polymyxin B and bacteriophage tail fiber protein. Anal. Chim. Acta 2021, 1180, 338855 1IF 6.56.(共同一作)

6. He Yong, Zhao Hang, Liu Yuanwen, Zhou He. Specific and rapid reverse assaying protocol for detection and antimicrobial susceptibility testing of Pseudomonas aeruginosa based on dual molecular recognition. Sci. Rep. 2021, 11, 111013IF 4.38.(第一作者)

7. Li Jizhou, Xue Jinxia, Zhang Yu, He Yong, Fu Zhifeng. Shape-encoded functional hydrogel pellets for multiplexed detection of pathogenic bacteria using a gas pressure sensor. ACS Sens. 2022, 7, 2438-2445 1IF 9.168.(通讯作者)

8. Zhang Yu, Li Jizhou, Ma Yuchan, He Yong, Fu Zhifeng. Small ubiquitin-related modifier-fused bacteriophage tail fiber protein with favorable aqueous solubility for lateral flow assay of Pseudomonas aeruginosa. Biosens. Bioelectron. 2022, 216, 1146371IF 12.545.(通讯作者)

9. Ma Yuchan, Zhang Yu, Gao Jiaqi, Ouyang Hui, He Yong, Fu Zhifeng. PEGylated Ni single-atom catalysts as ultrasensitive electrochemiluminescent probes with favorable aqueous dispersibility for assaying drug-resistant pathogens. Anal. Chem. 2022, 94, 14047-14053 1IF 8.008)(通讯作者)

10. Zhu Zhongjie, Zhang Yu, Xue Jinxia, Kong Jing, Huang Ling, Ouyang Hui, Fu Zhifeng, He Yong. Fluorescent immunochromatographic test strip for therapeutic drug monitoring of methotrexate with high sensitivity and wide dynamic range. Microchimica Acta, 2023, 190:342. (2, IF 5.7)(通讯作者)

11. Wu LuLu, Zhu Zhongjie, Xue Jinxia, Zheng Liang, Liu Hongmei, Ouyang Hui, Fu Zhifeng, He Yong. Chemiluminescent/photothermal dual-mode lateral flow immunoassay based on CoFe PBAs/WS2 nanozyme for rapid and highly sensitive point-of-care testing of gentamicin. Biosens Bioelectron 2024, 265, 116711. 1IF 10.7)(通讯作者)

12Tang Li, Liu Hongmei, Wu Shasha, Liu Jing, Jiang Xiaoyu, Fu Yuanyuan, Tao Na, He Yong. A point prevalence survey and monitoring indicator research on the second batch of national key monitoring and rational use drugs. Front Pharmacol 2024, 15, 1416010.2IF 4.4)(通讯作者)

 

 

 

更多我院平台二维码
微信公众号